Antonio Vallano
Biographic Data
| ID | 9999953 |
|---|---|
| NAME | Antonio Vallano |
| GIVEN NAMES | Antonio |
| FAMILY NAME | Vallano |
| SIGNATURE | VALLANO A |
| AFFILIATIONS | Universitat Autonòma de Barcelona |
| ORCID | 0000-0002-3648-3492 |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 2 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2022 |
| LATEST PUBLICATION YEAR | 2024 |
| H-INDEX | 0 |
Escalating costs of innovative medicines: Perspective and proposals
Public healthcare systems are challenged by the soaring costs of medications that require increasing resources, often at the expense of other investments. The increasing pharmaceutical budget poses a threat to the allocation of funds for essential preventive and primary healthcare services while also raising concerns about equitable access, particularly in models where patients bear part of the costs out of their own pockets. Proposals on how to …
Dealing With Immunoglobulin Shortages: A Rationalization Plan From Evidence-Based and Data Collection
Background The demand and consumption of immunoglobulins (IgGs) are growing, and there are many difficulties in obtaining supplies. The aim of the study was to analyze the evolution of IgG consumption and cost over a decade, describe the measures implemented for clinical management in the context of regional public health system, and evaluate the initial impact of these measures. Methods We performed a retrospective longitudinal study including p…
No prominent works on this page.
Dealing With Immunoglobulin Shortages: A Rationalization Plan From Evidence-Based and Data Collection
Background The demand and consumption of immunoglobulins (IgGs) are growing, and there are many difficulties in obtaining supplies. The aim of the study was to analyze the evolution of IgG consumption and cost over a decade, describe the measures implemented for clinical management in the context of regional public health system, and evaluate the initial impact of these measures. Methods We performed a retrospective longitudinal study including p…
Escalating costs of innovative medicines: Perspective and proposals
Public healthcare systems are challenged by the soaring costs of medications that require increasing resources, often at the expense of other investments. The increasing pharmaceutical budget poses a threat to the allocation of funds for essential preventive and primary healthcare services while also raising concerns about equitable access, particularly in models where patients bear part of the costs out of their own pockets. Proposals on how to …
Blood donation and transfusion practices (1 works) · Business (1 works) · Cognitive reframing (1 works) · Demography (1 works) · Economics (1 works) · Environmental health (1 works) · Finance (1 works) · Geography (1 works) · Health care (1 works) · Health Systems, Economic Evaluations, Quality of Life (1 works)